Skip to main content
logo
Hamps Bio Limited (BOM:544312)
India flag India · Delayed Price · Currency is INR
24.30
0.00 (0.00%)
At close: Jul 24, 2026

Hamps Bio Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
84.7584.7566.6964.7555.7853.4
Revenue Growth
19.02%27.08%2.99%16.08%4.45%39.71%
Gross Profit
53.153.145.4146.6636.7330.69
Operating Income
-7.83-7.834.137.885.282.9
Net Income
-7.39-7.392.985.013.591.22
Earnings Per Share
-0.85-0.850.341.270.670.23
EPS Growth
---73.33%90.30%197.78%-

Revenue by Segment
Chart
Fiscal YearTTMFY 2026FY 2025
Period EndingMar '26 Mar '26 Mar '25
Pharma Products
44.3544.3534.76
Freeze Dried Products
40.440.431.93
Total
84.7584.7566.69

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
1.71.70.960.580.490.51
Total Debt
68.8368.8329.6710.4517.3820.43
Net Cash (Debt)
-67.13-67.13-28.72-9.87-16.89-19.92
Net Cash Growth
------
Net Cash Per Share
-7.72-7.72-3.30-2.52-3.16-3.72

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-7.78-7.78-17.68-2.9212.33.33
Capital Expenditures
-51.33-51.33-37.19-3.62-8.29-2.91
Free Cash Flow
-59.11-59.11-54.88-6.5440.42
Free Cash Flow Growth
----860.19%-

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
62.66%62.66%68.10%72.05%65.85%57.48%
Operating Margin
-9.24%-9.24%6.19%12.17%9.46%5.43%
Pretax Margin
-8.26%-8.26%6.06%10.04%6.40%1.96%
Profit Margin
-8.72%-8.72%4.46%7.73%6.44%2.27%
FCF Margin
-69.75%-69.75%-82.29%-10.09%7.18%0.78%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
--62.55---
PS Ratio
2.501.702.79---